• Agreement increases Hormonal Therapies reach across EU

News & Views

Agreement increases Hormonal Therapies reach across EU

May 20 2022

Pharmaceutical organisation Diurnal Group has extended its agreement with Er-Kim for the distribution and marketing of its encapsulated hydrocortisone granules targeting chronic endocrine (hormonal) diseases, in Greece, Cyprus and Malta.

 The combined market opportunity for these three countries has been estimated to be approximately €7m in paediatric adrenal insufficiency (AI) and adult congenital adrenal hyperplasia (CAH). Er-Kim already holds distribution and marketing rights for supplying these products to Turkey, Romania and Bulgaria.

Diurnal’s licensed preparation of hydrocortisone, Alkindi®, approved in the UK, the European Economic Area, Israel, Australia, Switzerland and the US, is specifically designed for use in children suffering from AI, including the related CAH.  

The company’s Efmody® is a modified-release preparation of hydrocortisone for the treatment of patients with CAH, a rare condition caused by a genetic deficiency of adrenal enzymes. In May 2021, this was granted marketing authorisation in the European Union and was launched by the Company in Germany, Austria and the UK during September that year.

Richard Bungay, Interim Chief Executive Officer and Chief Financial Officer of Diurnal, commented:

“Following this latest agreement with Er-Kim, we are pleased that the Company’s commercial footprint now reaches 70% of the European Union population.”

Cem Zorlular, Chairman and Chief Executive Officer of Er-Kim, said:

“We are pleased to expand our collaboration with Diurnal after a year of working relentlessly to execute on our shared vision of addressing unmet rare endocrine conditions in Turkey, Romania and Bulgaria. We are very excited to have the opportunity to now provide market access to much needed paediatric and adult cortisol deficiency treatments in Greece, Malta, Cyprus.”

More information online

Digital Edition

International Labmate Buyers Guide 2022

June 2022

In This Edition Evaluation of Recovery of Basic Analytes Using a Mixed-Mode Strong Cation Exchange SPE Microplate by HPLC-MS The Benefits of SEC-MALLS in Biopharmaceutical Applications...

View all digital editions


AACC Annual Meeting & Clinical Lab Expo

Jul 24 2022 Chicago, IL, USA

ICMGP 2022

Jul 24 2022 Virtual event

ACS National Meeting & Expo, Fall 2022

Aug 21 2022 Chicago, IL, USA & Online


Aug 22 2022 Frankfurt, Germany

IMSC 2022

Aug 27 2022 Maastricht, Netherlands

View all events